Click here to get full coverage on SkinJect microneedle clears 73% of basal cell tumors in Phase 2 trial - Stock Titan

SkinJect microneedle clears 73% of basal cell tumors in Phase 2 trial  Stock Titan

SkinJect microneedle clears 73% of basal cell tumors in Phase 2 trial - Stock Titan

Click here to get full coverage on Medicus Pharma to highlight positive Phase 2 SkinJect data during webcast with lead investigator - Proactive financial news

Medicus Pharma to highlight positive Phase 2 SkinJect data during webcast with lead investigator  Proactive financial news

Medicus Pharma to highlight positive Phase 2 SkinJect data during webcast with lead investigator - Proactive financial news

Click here to get full coverage on Medicus Pharma Highlights Strong Phase 2 SkinJect Data Ahead of Business Update Call - TipRanks

Medicus Pharma Highlights Strong Phase 2 SkinJect Data Ahead of Business Update Call  TipRanks

Medicus Pharma Highlights Strong Phase 2 SkinJect Data Ahead of Business Update Call - TipRanks

Click here to get full coverage on Medicus Pharma on Bloomberg World - Detroit Free Press

Medicus Pharma on Bloomberg World  Detroit Free Press

Medicus Pharma on Bloomberg World - Detroit Free Press

Click here to get full coverage on Medicus Pharma schedules webcast on basal cell carcinoma study - Investing.com

Medicus Pharma schedules webcast on basal cell carcinoma study  Investing.com

Medicus Pharma schedules webcast on basal cell carcinoma study - Investing.com

Click here to get full coverage on Lockheed Martin Demos Next-Gen Multi-Domain Autonomy - Lockheed Martin

Lockheed Martin Demos Next-Gen Multi-Domain Autonomy  Lockheed Martin

Lockheed Martin Demos Next-Gen Multi-Domain Autonomy - Lockheed Martin

Click here to get full coverage on Market Movers | Winners: MMED, TVGN, PRSO | Losers: CLDI, IMG, MDCX - Trefis

Market Movers | Winners: MMED, TVGN, PRSO | Losers: CLDI, IMG, MDCX  Trefis

Market Movers | Winners: MMED, TVGN, PRSO | Losers: CLDI, IMG, MDCX - Trefis

Click here to get full coverage on New to The Street Episode #737 Airs on Bloomberg Television Across the United States, Latin America, and MENA at 6:30 PM EST - Macon Telegraph

New to The Street Episode #737 Airs on Bloomberg Television Across the United States, Latin America, and MENA at 6:30 PM EST  Macon Telegraph

New to The Street Episode #737 Airs on Bloomberg Television Across the United States, Latin America, and MENA at 6:30 PM EST - Macon Telegraph

Click here to get full coverage on Microneedle skin cancer patch shows 73% clearance in Medicus trial - Stock Titan

Microneedle skin cancer patch shows 73% clearance in Medicus trial  Stock Titan

Microneedle skin cancer patch shows 73% clearance in Medicus trial - Stock Titan

Click here to get full coverage on Maxim Group Reaffirms Buy on Medicus Pharma Ltd (MDCX) With $20 Target - Yahoo Finance

Maxim Group Reaffirms Buy on Medicus Pharma Ltd (MDCX) With $20 Target  Yahoo Finance

Maxim Group Reaffirms Buy on Medicus Pharma Ltd (MDCX) With $20 Target - Yahoo Finance

Click here to get full coverage on Medicus Pharma CEO discusses promising Phase 2 SkinJect results - ICYMI - Proactive financial news

Medicus Pharma CEO discusses promising Phase 2 SkinJect results - ICYMI  Proactive financial news

Medicus Pharma CEO discusses promising Phase 2 SkinJect results - ICYMI - Proactive financial news

Click here to get full coverage on Market Movers | Winners: TVGN, TPET, IBO | Losers: IMG, MDCX, SES - Trefis

Market Movers | Winners: TVGN, TPET, IBO | Losers: IMG, MDCX, SES  Trefis

Market Movers | Winners: TVGN, TPET, IBO | Losers: IMG, MDCX, SES - Trefis

Click here to get full coverage on SkinJect cancer patch clears 3 in 4 lesions in trial, may spare surgery - Stock Titan

SkinJect cancer patch clears 3 in 4 lesions in trial, may spare surgery  Stock Titan

SkinJect cancer patch clears 3 in 4 lesions in trial, may spare surgery - Stock Titan

Click here to get full coverage on Medicus Pharma (MDCX) sells 4.47M shares to Yorkville and prepays part of debenture - Stock Titan

Medicus Pharma (MDCX) sells 4.47M shares to Yorkville and prepays part of debenture  Stock Titan

Medicus Pharma (MDCX) sells 4.47M shares to Yorkville and prepays part of debenture - Stock Titan

Click here to get full coverage on Medicus Pharma (MDCX) registers 1.12M shares; Yorkville bought 4.47M shares - Stock Titan

Medicus Pharma (MDCX) registers 1.12M shares; Yorkville bought 4.47M shares  Stock Titan

Medicus Pharma (MDCX) registers 1.12M shares; Yorkville bought 4.47M shares - Stock Titan

Click here to get full coverage on Market Movers | Winners: MMED, TVGN, PRSO | Losers: CLDI, MDCX, CCHH - Trefis

Market Movers | Winners: MMED, TVGN, PRSO | Losers: CLDI, MDCX, CCHH  Trefis

Market Movers | Winners: MMED, TVGN, PRSO | Losers: CLDI, MDCX, CCHH - Trefis

Click here to get full coverage on MDCX Maintains Buy Rating with Stable Price Target | MDCX Stock News - GuruFocus

MDCX Maintains Buy Rating with Stable Price Target | MDCX Stock News  GuruFocus

MDCX Maintains Buy Rating with Stable Price Target | MDCX Stock News - GuruFocus

Click here to get full coverage on Skunk Works® and XTEND Expand Joint All Domain Command and Control for Advanced Mission Execution - Lockheed Martin

Skunk Works® and XTEND Expand Joint All Domain Command and Control for Advanced Mission Execution  Lockheed Martin

Skunk Works® and XTEND Expand Joint All Domain Command and Control for Advanced Mission Execution - Lockheed Martin

Click here to get full coverage on Medicus Pharma to spotlight AI-driven drug development at Longwood Miami CEO Forum - Proactive financial news

Medicus Pharma to spotlight AI-driven drug development at Longwood Miami CEO Forum  Proactive financial news

Medicus Pharma to spotlight AI-driven drug development at Longwood Miami CEO Forum - Proactive financial news

Click here to get full coverage on Medicus Pharma Marks Nasdaq Anniversary with Opening Bell Ceremony - The Globe and Mail

Medicus Pharma Marks Nasdaq Anniversary with Opening Bell Ceremony  The Globe and Mail

Medicus Pharma Marks Nasdaq Anniversary with Opening Bell Ceremony - The Globe and Mail

Click here to get full coverage on Medicus Pharma CEO discusses Phase 2 skin cancer results - ICYMI - Proactive financial news

Medicus Pharma CEO discusses Phase 2 skin cancer results - ICYMI  Proactive financial news

Medicus Pharma CEO discusses Phase 2 skin cancer results - ICYMI - Proactive financial news

Click here to get full coverage on New to The Street to Broadcast Executive Leadership Interviews Featuring Medicus Pharma Ltd. (NASDAQ:MDCX), CitroTech (NYSE:CITR), Vivos Therapeutics, Inc. (NASDAQ:VVOS), and Virtuix Holdings ($VTIX) on Bloomberg Television Tonight at 6:30 PM - galvnews.com

New to The Street to Broadcast Executive Leadership Interviews Featuring Medicus Pharma Ltd. (NASDAQ:MDCX), CitroTech (NYSE:CITR), Vivos Therapeutics, Inc. (NASDAQ:VVOS), and Virtuix Holdings ($VTIX) on Bloomberg Television Tonight at 6:30 PM  galvnews.com

New to The Street to Broadcast Executive Leadership Interviews Featuring Medicus Pharma Ltd. (NASDAQ:MDCX), CitroTech (NYSE:CITR), Vivos Therapeutics, Inc. (NASDAQ:VVOS), and Virtuix Holdings ($VTIX) on Bloomberg Television Tonight at 6:30 PM - galvnews.com

Click here to get full coverage on MDCX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

MDCX Financials: Income Statement, Balance Sheet & Cash Flow  Stock Titan

MDCX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Click here to get full coverage on Medicus Pharma (NASDAQ: MDCX) enters $5.1M warrant deal, issues new 4.02M warrants - Stock Titan

Medicus Pharma (NASDAQ: MDCX) enters $5.1M warrant deal, issues new 4.02M warrants  Stock Titan

Medicus Pharma (NASDAQ: MDCX) enters $5.1M warrant deal, issues new 4.02M warrants - Stock Titan

Click here to get full coverage on AI data crunching aims to speed testing of new prostate cancer drug - Stock Titan

AI data crunching aims to speed testing of new prostate cancer drug  Stock Titan

AI data crunching aims to speed testing of new prostate cancer drug - Stock Titan

Click here to get full coverage on 3/6/2026 Market Update - Winners: MMED, TVGN, PRSO - Losers: CLDI, MDCX, CCHH - S&P 500: -1.3% - Trefis

3/6/2026 Market Update - Winners: MMED, TVGN, PRSO - Losers: CLDI, MDCX, CCHH - S&P 500: -1.3%  Trefis

3/6/2026 Market Update - Winners: MMED, TVGN, PRSO - Losers: CLDI, MDCX, CCHH - S&P 500: -1.3% - Trefis

Click here to get full coverage on Medicus Pharma’s Teverelix Phase 2b trial cleared by FDA - ICYMI | NASDAQ:MDCX - Proactive financial news

Medicus Pharma’s Teverelix Phase 2b trial cleared by FDA - ICYMI | NASDAQ:MDCX  Proactive financial news

Medicus Pharma’s Teverelix Phase 2b trial cleared by FDA - ICYMI | NASDAQ:MDCX - Proactive financial news

Click here to get full coverage on Medicus Pharma (NASDAQ: MDCX) seeks FDA CNPV for SKNJCT-003 to treat BCC skin cancer - Stock Titan

Medicus Pharma (NASDAQ: MDCX) seeks FDA CNPV for SKNJCT-003 to treat BCC skin cancer  Stock Titan

Medicus Pharma (NASDAQ: MDCX) seeks FDA CNPV for SKNJCT-003 to treat BCC skin cancer - Stock Titan

Click here to get full coverage on New to The Street to Broadcast Executive Leadership Interviews Featuring Medicus Pharma Ltd. (NASDAQ:MDCX), CitroTech (NYSE:CITR), Vivos Therapeutics, Inc. (NASDAQ:VVOS), and Virtuix Holdings ($VTIX) on Bloomberg Television Tonight at 6:30 PM - Newswire.com

New to The Street to Broadcast Executive Leadership Interviews Featuring Medicus Pharma Ltd. (NASDAQ:MDCX), CitroTech (NYSE:CITR), Vivos Therapeutics, Inc. (NASDAQ:VVOS), and Virtuix Holdings ($VTIX) on Bloomberg Television Tonight at 6:30 PM  Newswire.com

New to The Street to Broadcast Executive Leadership Interviews Featuring Medicus Pharma Ltd. (NASDAQ:MDCX), CitroTech (NYSE:CITR), Vivos Therapeutics, Inc. (NASDAQ:VVOS), and Virtuix Holdings ($VTIX) on Bloomberg Television Tonight at 6:30 PM - Newswire.com

Click here to get full coverage on Medicus Pharma Raises Equity Financing, Reduces Yorkville Debenture - The Globe and Mail

Medicus Pharma Raises Equity Financing, Reduces Yorkville Debenture  The Globe and Mail

Medicus Pharma Raises Equity Financing, Reduces Yorkville Debenture - The Globe and Mail

Click here to get full coverage on Medicus Pharma to present at Roth Conference - Proactive financial news

Medicus Pharma to present at Roth Conference  Proactive financial news

Medicus Pharma to present at Roth Conference - Proactive financial news

Click here to get full coverage on Medicus Pharma prices $7 million share offering - MSN

Medicus Pharma prices $7 million share offering  MSN

Medicus Pharma prices $7 million share offering - MSN

Click here to get full coverage on Medicus Pharma on Bloomberg World - The Providence Journal

Medicus Pharma on Bloomberg World  The Providence Journal

Medicus Pharma on Bloomberg World - The Providence Journal

Click here to get full coverage on Medicus says Phase 2 data supports further development of SkinJect therapy for skin cancer - Proactive financial news

Medicus says Phase 2 data supports further development of SkinJect therapy for skin cancer  Proactive financial news

Medicus says Phase 2 data supports further development of SkinJect therapy for skin cancer - Proactive financial news

Click here to get full coverage on Medicus Pharma on Bloomberg World - The Oklahoman

Medicus Pharma on Bloomberg World  The Oklahoman

Medicus Pharma on Bloomberg World - The Oklahoman

Click here to get full coverage on Single hormone shot kept levels low for weeks with no short-term bone loss - Stock Titan

Single hormone shot kept levels low for weeks with no short-term bone loss  Stock Titan

Single hormone shot kept levels low for weeks with no short-term bone loss - Stock Titan

Click here to get full coverage on FDA clears trial of Teverelix for prostate cancer with high heart risk - Stock Titan

FDA clears trial of Teverelix for prostate cancer with high heart risk  Stock Titan

FDA clears trial of Teverelix for prostate cancer with high heart risk - Stock Titan

Click here to get full coverage on Medicus Pharma provides additional Phase 2 data for SkinJect Cancer therapy - Proactive financial news

Medicus Pharma provides additional Phase 2 data for SkinJect Cancer therapy  Proactive financial news

Medicus Pharma provides additional Phase 2 data for SkinJect Cancer therapy - Proactive financial news

Click here to get full coverage on Medicus Pharma reports positive Phase 2 results for microneedle treatment for basal cell carcinoma - Proactive financial news

Medicus Pharma reports positive Phase 2 results for microneedle treatment for basal cell carcinoma  Proactive financial news

Medicus Pharma reports positive Phase 2 results for microneedle treatment for basal cell carcinoma - Proactive financial news

Click here to get full coverage on Medicus Pharma Ltd. To Participate In The Longwood Miami CEO Forum - Voice of Alexandria

Medicus Pharma Ltd. To Participate In The Longwood Miami CEO Forum  Voice of Alexandria

Medicus Pharma Ltd. To Participate In The Longwood Miami CEO Forum - Voice of Alexandria

Click here to get full coverage on Skunk Works Integrates XTEND C2 Software Into MDCX Platform - ExecutiveBiz

Skunk Works Integrates XTEND C2 Software Into MDCX Platform  ExecutiveBiz

Skunk Works Integrates XTEND C2 Software Into MDCX Platform - ExecutiveBiz

Click here to get full coverage on New to The Street to Broadcast Executive Leadership Interviews Featuring Medicus Pharma Ltd. (NASDAQ:MDCX), CitroTech (NYSE:CITR), Vivos Therapeutics, Inc. (NASDAQ:VVOS), and Virtuix Holdings ($VTIX) on Bloomberg Television Tonight at 6:30 PM - Eagle-Tribune

New to The Street to Broadcast Executive Leadership Interviews Featuring Medicus Pharma Ltd. (NASDAQ:MDCX), CitroTech (NYSE:CITR), Vivos Therapeutics, Inc. (NASDAQ:VVOS), and Virtuix Holdings ($VTIX) on Bloomberg Television Tonight at 6:30 PM  Eagle-Tribune

New to The Street to Broadcast Executive Leadership Interviews Featuring Medicus Pharma Ltd. (NASDAQ:MDCX), CitroTech (NYSE:CITR), Vivos Therapeutics, Inc. (NASDAQ:VVOS), and Virtuix Holdings ($VTIX) on Bloomberg Television Tonight at 6:30 PM - Eagle-Tribune

Click here to get full coverage on American Lithium Minerals (OTC: AMLM) Targets Tokenized Commodities Opportunity Alongside MDCX, ASNS, EONR, ELPW Today! - marketscreener.com

American Lithium Minerals (OTC: AMLM) Targets Tokenized Commodities Opportunity Alongside MDCX, ASNS, EONR, ELPW Today!  marketscreener.com

American Lithium Minerals (OTC: AMLM) Targets Tokenized Commodities Opportunity Alongside MDCX, ASNS, EONR, ELPW Today! - marketscreener.com

Click here to get full coverage on Medicus Pharma Provides Interpretation of Positive Phase 2 SkinJect™ Dataset - Sahm

Medicus Pharma Provides Interpretation of Positive Phase 2 SkinJect™ Dataset  Sahm

Medicus Pharma Provides Interpretation of Positive Phase 2 SkinJect™ Dataset - Sahm

Click here to get full coverage on Medicus Pharma on Bloomberg World - Corning Leader

Medicus Pharma on Bloomberg World  Corning Leader

Medicus Pharma on Bloomberg World - Corning Leader

Click here to get full coverage on Medicus Pharma Stock Swings After Skin Cancer Treatment Results - Benzinga

Medicus Pharma Stock Swings After Skin Cancer Treatment Results  Benzinga

Medicus Pharma Stock Swings After Skin Cancer Treatment Results - Benzinga

Click here to get full coverage on Medicus Pharma Marks Nasdaq Anniversary With Opening Bell Ceremony - Visalia Times-Delta

Medicus Pharma Marks Nasdaq Anniversary With Opening Bell Ceremony  Visalia Times-Delta

Medicus Pharma Marks Nasdaq Anniversary With Opening Bell Ceremony - Visalia Times-Delta

Click here to get full coverage on Medicus Pharma to Spotlight AI-Driven Drug Development at Longwood Miami CEO Forum - TipRanks

Medicus Pharma to Spotlight AI-Driven Drug Development at Longwood Miami CEO Forum  TipRanks

Medicus Pharma to Spotlight AI-Driven Drug Development at Longwood Miami CEO Forum - TipRanks

Click here to get full coverage on Medicus Pharma on Bloomberg World - Sarasota Herald-Tribune

Medicus Pharma on Bloomberg World  Sarasota Herald-Tribune

Medicus Pharma on Bloomberg World - Sarasota Herald-Tribune

Click here to get full coverage on Medicus Pharma Ltd. Rings the Opening Bell - Nasdaq

Medicus Pharma Ltd. Rings the Opening Bell  Nasdaq

Medicus Pharma Ltd. Rings the Opening Bell - Nasdaq

Click here to get full coverage on Skunk Works and XTEND Simplify Multi-Drone Command - Defense Update

Skunk Works and XTEND Simplify Multi-Drone Command  Defense Update

Skunk Works and XTEND Simplify Multi-Drone Command - Defense Update

Click here to get full coverage on Lockheed Martin integrates MDCX with Xtend's XOS for unmanned control - Janes

Lockheed Martin integrates MDCX with Xtend's XOS for unmanned control  Janes

Lockheed Martin integrates MDCX with Xtend's XOS for unmanned control - Janes

Click here to get full coverage on New Analyst Forecast: $MDCX Given 'Buy' Rating - Nasdaq

New Analyst Forecast: $MDCX Given 'Buy' Rating  Nasdaq

New Analyst Forecast: $MDCX Given 'Buy' Rating - Nasdaq

Click here to get full coverage on Medicus Pharma on Bloomberg World - Burlington County Times

Medicus Pharma on Bloomberg World  Burlington County Times

Medicus Pharma on Bloomberg World - Burlington County Times

Click here to get full coverage on Medicus Pharma on Bloomberg World - Savannah Morning News

Medicus Pharma on Bloomberg World  Savannah Morning News

Medicus Pharma on Bloomberg World - Savannah Morning News

Click here to get full coverage on Medicus Pharma lowers royalty burden on prostate cancer drug Teverelix - Proactive financial news

Medicus Pharma lowers royalty burden on prostate cancer drug Teverelix  Proactive financial news

Medicus Pharma lowers royalty burden on prostate cancer drug Teverelix - Proactive financial news

Click here to get full coverage on Medicus Pharma CEO discusses Phase 2 skin cancer results - ICYMI - Proactive Investors

Medicus Pharma CEO discusses Phase 2 skin cancer results - ICYMI  Proactive Investors

Medicus Pharma CEO discusses Phase 2 skin cancer results - ICYMI - Proactive Investors

Click here to get full coverage on New to The Street to Broadcast Executive Leadership Interviews Featuring Medicus Pharma Ltd. (NASDAQ:MDCX), CitroTech (NYSE:CITR), Vivos Therapeutics, Inc. (NASDAQ:VVOS), and Virtuix Holdings ($VTIX) on Bloomberg Television Tonight at 6:30 PM - lincolnjournal.com

New to The Street to Broadcast Executive Leadership Interviews Featuring Medicus Pharma Ltd. (NASDAQ:MDCX), CitroTech (NYSE:CITR), Vivos Therapeutics, Inc. (NASDAQ:VVOS), and Virtuix Holdings ($VTIX) on Bloomberg Television Tonight at 6:30 PM  lincolnjournal.com

New to The Street to Broadcast Executive Leadership Interviews Featuring Medicus Pharma Ltd. (NASDAQ:MDCX), CitroTech (NYSE:CITR), Vivos Therapeutics, Inc. (NASDAQ:VVOS), and Virtuix Holdings ($VTIX) on Bloomberg Television Tonight at 6:30 PM - lincolnjournal.com

Click here to get full coverage on Medicus Pharma Ltd. Rings the Nasdaq Stock Market Opening Bell - Nasdaq

Medicus Pharma Ltd. Rings the Nasdaq Stock Market Opening Bell  Nasdaq

Medicus Pharma Ltd. Rings the Nasdaq Stock Market Opening Bell - Nasdaq

Click here to get full coverage on Medicus Pharma on Bloomberg World - Shreveport Times

Medicus Pharma on Bloomberg World  Shreveport Times

Medicus Pharma on Bloomberg World - Shreveport Times

Click here to get full coverage on Medicus Pharma Marks Nasdaq Anniversary With Opening Bell Ceremony - Salina Journal

Medicus Pharma Marks Nasdaq Anniversary With Opening Bell Ceremony  Salina Journal

Medicus Pharma Marks Nasdaq Anniversary With Opening Bell Ceremony - Salina Journal

Click here to get full coverage on Medicus Pharma’s teverelix data accepted for presentation at AACE 2026 - Investing.com

Medicus Pharma’s teverelix data accepted for presentation at AACE 2026  Investing.com

Medicus Pharma’s teverelix data accepted for presentation at AACE 2026 - Investing.com

Click here to get full coverage on Medicus Pharma on Bloomberg World - Cincinnati Enquirer

Medicus Pharma on Bloomberg World  Cincinnati Enquirer

Medicus Pharma on Bloomberg World - Cincinnati Enquirer

Click here to get full coverage on Medicus Pharma Ltd. Appoints Carolyn Bonner as Chief Financial Officer in Addition to Her Role as President - GlobeNewswire

Medicus Pharma Ltd. Appoints Carolyn Bonner as Chief Financial Officer in Addition to Her Role as President  GlobeNewswire

Medicus Pharma Ltd. Appoints Carolyn Bonner as Chief Financial Officer in Addition to Her Role as President - GlobeNewswire

Click here to get full coverage on Medicus Pharma Ltd. Celebrates One Year on Nasdaq with Opening Bell Ceremony on January 22, 2026 - Yahoo Finance

Medicus Pharma Ltd. Celebrates One Year on Nasdaq with Opening Bell Ceremony on January 22, 2026  Yahoo Finance

Medicus Pharma Ltd. Celebrates One Year on Nasdaq with Opening Bell Ceremony on January 22, 2026 - Yahoo Finance

Click here to get full coverage on Medicus Pharma on Bloomberg World - Democrat and Chronicle

Medicus Pharma on Bloomberg World  Democrat and Chronicle

Medicus Pharma on Bloomberg World - Democrat and Chronicle

Click here to get full coverage on Medicus Pharma on Bloomberg World - Columbia Daily Tribune

Medicus Pharma on Bloomberg World  Columbia Daily Tribune

MDCX

Price Chart

Key Statistics

Technicals

About MDCX

Latest News

SkinJect microneedle clears 73% of basal cell tumors in Phase 2 trial - Stock Titan

Medicus Pharma to highlight positive Phase 2 SkinJect data during webcast with lead investigator - Proactive financial news

Medicus Pharma Highlights Strong Phase 2 SkinJect Data Ahead of Business Update Call - TipRanks

Advanced Charts

Top Gainers

Top Losers